Cite
HARVARD Citation
Garnham, K. et al. (2022). Introducing 1, 3‐beta‐d‐glucan for screening and diagnosis of invasive fungal diseases in Australian high‐risk haematology patients: is there a clinical benefit?. Internal medicine journal. 52 (3), pp. 426-435. [Online].